Senior Fellow, President at Boston Cancer Policy Institute.
About Ellie Okada
The Senior Fellow, President of the Boston Cancer Policy Institute, Ellie Okada is a respected social scientist, business strategist, and academic. The Institute aims to research mechanisms that will advance paths towards personalized cancer medicine: social science research that will accelerate translational medicine, provision of increased options for unmet needs, and improvement of cancer /science policy outcomes. As the senior fellow of the Institute, Ellie Okada is committed to putting her knowledge and experience to explore frameworks with regulatory policies in mind.
Ellie Okada holds a Ph.D. in Business Administration from Kobe University’s rigorous Graduate School of Business Administration program, which required Ms. Okada to complete 10 years of teaching in addition to her doctoral thesis before receiving her degree. From 1988 until 2012, she taught and researched at the Yokohama National University. While a professor, she came to the U.S. to serve at both Columbia University and Harvard University. As a visiting scholar at Columbia, she developed workable configurations of internal and external intellectual property to leverage organizational capability change. During her later work as an academic associate at Harvard, Ellie Okada began to incorporate elements of the policy formulation framework into the management theory that was derived from the economics field.
Recognized by the Japanese Government as an expert in her field, Ellie Okada served on the Japanese Cabinet Office’s Council for Science and Technology between 2007 and 2009, during which time she aided in synchronizing intellectual property guidelines in the advanced medical treatments field for the United States and Japan.
In 2012, Ellie Okada resigned her position as a tenured professor in order to pursue her research on mechanisms of personalized therapeutics and diagnostics with bioethics considerations, an option only available in the United States. Her personal research and remarks at the Council for Science and Technology have consistently been in harmony with the goals of Innovate America, a publication put out by the Council of Competitiveness. Ellie Okada has permanently relocated to Boston, where she is concentrating on continued research and her work at the Boston Cancer Policy Institute.